Two groups studied the same cancer mutations in the blood. They agreed on many aspects, including the mechanism at work. But ...
A new study shows cancer genes are not destiny: genetic background can shape whether inherited cancer risk becomes disease, when it begins, and how it develops.
Pharmaceutical partners Moderna and Merck announced on Wednesday that their novel mRNA-based vaccine—individually tailored to ...
Researchers at the University of Oslo and Oslo University Hospital have developed a promising new immunotherapy targeting the CTNNB1 gene mutation associated with various aggressive cancers such as ...
The Chosun Ilbo on MSN
CRISPR-based CINDELA targets cancer DNA mutations selectively
A South Korean research team is developing an anticancer technology that selectively targets and removes DNA mutations found ...
A single sperm donor who carries a rare cancer-causing genetic mutation has fathered at least 197 children across 14 countries in Europe, according to a collaborative investigation by 14 European news ...
Cancer is often thought of as a single disease. Yet even tumors that arise in the same organ can follow very different genetic paths. A new study shows that these differences can sometimes be traced ...
The Chosun Ilbo on MSN
CRISPR anticancer tech targets cancer mutations, spares healthy cells
A domestic research team is developing an anticancer technology that attacks DNA mutations found only in cancer cells while ...
Combining a vaccine and immunotherapy approach could open new ways to treat cancer.
Developers believe the study is the first-in-human demonstration for a drug that could safely prevent its development.
Researchers at the University of Oslo and Oslo University Hospital have developed a promising new immunotherapy targeting the CTNNB1 gene mutation associated with various aggressive cancers like lung ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results